Raymond Reding, Jérémie Gras, Dinh Quang Truong, Grégoire Wieërs, Dominique Latinne – 23 February 2006 – The aim of this work is to review the current knowledge in the field of immunological monitoring of allogenic responsiveness in clinical liver transplantation. When compared to other solid‐organ transplants, liver allografts are considered as immunologically privileged, and, accordingly, constitute a favorable setting to develop experimental as well as clinical strategies for minimization of immunosuppression and even induction of operational tolerance.

Takehisa Ueno, Greg Jones, Adrian Martin, Toru Ikegami, Edmund Q. Sanchez, Srinath Chinnakotla, Henry B. Randall, Marlon F. Levy, Robert M. Goldstein, Goran B. Klintmalm – 23 February 2006 – Hepatic artery stenosis after liver transplantation may affect liver function and result in hepatic artery thrombosis. Surgical reconstruction has been the first choice for treatment. Interventional radiologic technique can be used, but there is no report on long‐term outcome. The aim of this paper is to assess current outcome and complications of hepatic artery stenting.

Shahid Habib, Obaid Shakil, Osvaldo F. Couto, Anthony J. Demetris, John J. Fung, Amadeo Marcos, Kapil Chopra – 23 February 2006 – Caroli's disease is a rare congenital hepatic disease, characterized by segmental dilatation of the biliary tree. Patients who have recurrent bouts of biliary infection, particularly those with complications related to portal hypertension, may require orthotopic liver transplantation (OLT). Few case reports have described the outcome of OLT in patients with Caroli's disease and to date there is no large series reported in the literature.

Silvio Nadalin, Massimo Malagó, Giuliano Testa, Randolph Schaffer, Georgios C. Sotiropoulos, Andrea Frilling, Christoph E. Broelsch – 23 February 2006 – In this study, we present our experience with 4 healthy donors having the rare condition of “hepar divisum” after the intraoperative death of the recipient of an intended right adult living donor liver transplantation (LDLT). The study included 4 donors and 4 intended right LDLT recipients affected by neuroendocrine tumor (n = 2), hepatocellular carcinoma (n = 1), and cryptogenic cirrhosis (n = 1). All 4 recipients died intraoperatively.

Joseph C. Yarze – 23 February 2006

23 February 2006

Yoshihisa Kodama, Yusuke Sakuhara, Daisuke Abo, Tsuyoshi Shimamura, Hiroyuki Furukawa, Satoru Todo, Kazuo Miyasaka – 23 February 2006 – The purpose of this study was to evaluate the efficacy of percutaneous transluminal angioplasty (PTA) for treatment of hepatic artery stenosis after living donor liver transplantation. Eighteen patients with hepatic artery stenosis after living donor liver transplantation were included in this study. The success rate and complications of PTA and recurrent stenosis of the hepatic artery were evaluated.

Massimo Cardillo, Nicola De Fazio, Paola Pedotti, Tullia De Feo, Luigi Rainero Fassati, Vincenzo Mazzaferro, Michele Colledan, Bruno Gridelli, Lucio Caccamo, Luciano DeCarlis, Umberto Valente, Enzo Andorno, Mariangelo Cossolini, Cristiano Martini, Adelmo Antonucci, Umberto Cillo, Giacomo Zanus, Umberto Baccarani, Mario Scalamogna, NITp Liver Transplantation Working Group – 23 February 2006 – A specific split liver transplantation (SLT) program has been pursued in the North Italian Transplant program (NITp) since November 1997.

Michael Wachs, James Trotter – 23 February 2006

Brenda M. Bosma, Herold J. Metselaar, Shanta Mancham, Partrick P.C. Boor, Johannes G. Kusters, Geert Kazemier, Hugo W. Tilanus, Ernst J. Kuipers, Jaap Kwekkeboom – 23 February 2006 – It is generally accepted that donor myeloid dendritic cells (MDC) are the main instigators of acute rejection after organ transplantation. The aim of the present study was to characterize MDC in human donor livers using liver grafts and perfusates as a source. Perfusates were collected during ex vivo vascular perfusion of liver grafts pretransplantation.